CRH Medical Announces Release Date for Third Quarter 2012 Results and Conference Call

VANCOUVER, Oct. 16, 2012 /CNW/ - CRH Medical Corporation (TSX: CRH, OTCQX: CRMMF), a North American medical company focussed on providing physicians with innovative products for the treatment of gastrointestinal diseases, today announced that it will release its financial results for the  third quarter  ended  September 30, 2012,  after the market close on Thursday, October 18, 2012. A telephone conference call hosted by management to discuss the quarter will be held:

Thursday, October 18, 2012 at 5:00 pm EST
The telephone numbers for the conference call are:
[phone] or [phone]

At the call's completion, an audio replay will be available by calling [phone] and using passcode 47908975. The phone replay will be available through November 1, 2012.

About CRH Medical Corporation:

CRH Medical Corporation is a North American company focussed on providing physicians with innovative products for the treatment of gastrointestinal diseases. The Company's lead product, the CRH O'Regan System, is a single use, disposable, hemorrhoid treatment that is safe and highly effective in treating hemorrhoid grades I - IV. The O'Regan System is rapidly emerging as the standard of care with gastroenterologists who treat hemorrhoids. In addition to the product, CRH Medical delivers clinical, marketing and operational support directly to its partner physicians. CRH utilizes its web-based platform to connect doctors with patients as well as educating its increasing install base of physicians.

SOURCE: CRH Medical Corporation

Edward Wright, Chief Executive Officer
CRH Medical Corporation
604.633.1440 x1008
[email protected]

or

Adam Peeler, Media and Investor Relations
TMX Equicom
416.815.0700 x 225
[email protected]